Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Cholesterol
 More »

  • Improving Proteomics Approaches
    ... The cell membrane is chemically heterogeneous (left). Lipid rafts, enriched in cholesterol and exhibiting local lipid ordering (light gray), sequester certain kinds of membrane ...
    5-15-2013
  • Study Points to Potential Biomarker for Atherosclerosis
    Thorin and his colleagues also found that angptl2, which is undetectable in young mice, increases with age in healthy animals, and prematurely so in those with high cholesterol and ...
    5-14-2013
  • Rethinking APOE's Role in Alzheimer's
    APOE is involved in the metabolism of fats, cholesterol, and vitamins throughout the body. Scientists have identified three different forms of the gene that each make a slightly ...
    5-8-2013
  • "GEN 10" Award Winners Announced
    myeloid leukemias Anne Thiel, Northwestern University, Abstract: Point-of-care cholesterol testing on a bioelectronic platform Srishti Tibrewala, Northwestern University, ...
    4-22-2013
  • Merck & Co. Picks Up Exclusive Option on Xenon CV Drugs
    year-vorapaxar for acute coronary syndrome chest pain caused by coronary artery disease, and K-524A (tredaptive), for LDL (bad cholesterol) to reduce incidence of vascular events. ...
    4-17-2013
  • Cytomics for Personalized Heart Health
    ... by smoking, high cholesterol levels, high blood pressure, diabetes, and other stressors. ... Current tests, such as cholesterol levels, do not give an accurate picture of ...
    4-15-2013
  • AstraZeneca Raises S&P Eyebrows
    ... sales for Seroquel IR, plus a combined $1 billion due to regional losses of patent protection for Nexium, blood pressure/heart failure drug Atacand, and cholesterol drug Crestor. ...
    4-9-2013
  • Top 20 Best-Selling Drugs Approved and Launched During 2012
    (obese) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related medical condition such as high blood pressure, type 2 diabetes, or high cholesterol. ...
    4-4-2013
  • Actavis Eyes 2016 Generic Crestor Launch After Settling Patent...
    Actavis said today it is planning a 2016 launch for its generic versions of AstraZeneca's cholesterol treatment rosuvastatin calcium (Crestor®) 5, 10, 20, and 40 mg tablets, after ...
    3-25-2013
  • New Biomarkers Could Offer Vital Clues for Cancer Research
    For example, blood pressure is now often used to determine the risk of stroke. It is also widely known that cholesterol values can act as a biomarker (and risk indicator) for ...
    3-21-2013
  • Zapping Pathological Proteins in Alzheimer's
    Because a single liposome can carry up to 400 antigens on its surface, it has a big, or "supra" impact. The liposomes, made of cholesterol and fatty acids, do not cause ...
    3-1-2013
  • Pricing Out Prescription Genomic Medicine
    in the form of aspirin resistance. 8,9 Of 60 million who take statins to lower cholesterol, three million experience muscle pain, elevated liver enzymes, or rhabdomyolysis as ...
    3-1-2013
  • Top 20 Best-Selling Drugs of 2012
    ... billion #15. Lipitor (atorvastatin calcium) Drug maker: Pfizer Indication(s): LDL cholesterol and triglyceride reduction in blood as adjunct therapy to diet; reduction of risks ...
    3-1-2013
  • Genomic Data in Patients' Hands
    ... develop based on a specific signature molecule. "What I have next in mind is using color assays for diseases such as diabetes or measuring cholesterol levels," says Dr. Hashsham. ...
    2-15-2013
  • Top 10 Biopharma Layoffs of 2012
    The company has seen sales declines tied to the loss of patent protection, notably for cholesterol-reduction drug Lipitor, which generated $9.6 billion in revenue in 2011 Projected ...
    2-15-2013
  • More »

    Journal Articles

  • Antihypertensive Treatment, High Triglycerides, and Low High...
    Poul Suadicani, Hans Ole Hein, Finn Gyntelberg
    Metabolic Syndrome and Related Disorders
    and Low High-Density Lipoprotein Cholesterol and Risk of Ischemic Heart Disease ... lipoprotein (HDL-C) and total cholesterol, glucosuria, electrocardiogram (ECG) ...
  • Metabolic Syndrome Prevalence, Dietary Intake, and Cardiovascular...
    Taif Al-Sarraj, Hussein Saadi, Jeff S. Volek, Maria Luz Fernandez
    Metabolic Syndrome and Related Disorders
    pressure >130/85 mmHg, triglycerides (TG) >1.7 mmol/L, and high-density lipoprotein cholesterol (HDL-C) <1.0 mmol/L in men and 1.7 mmol/L, whereas 95% had plasma LDL-C >2.6 mmol/L. ...
  • Association of Cardiometabolic Risk Factors and Prevalent Cardiovascul...
    Dan C. Malone, Denise M. Boudreau, Greg A. Nichols, Marsha A. Raebel, Paul A. Fishman, Adrianne C. Feldstein, Rami H. Ben-Joseph, Lynn J. Okamoto, Audra N. Boscoe, David J. Magid
    Metabolic Syndrome and Related Disorders
    July 1, 2003, to June 30, 2005. We used National Cholesterol Education Program Adult Treatment Panel III guidelines to determine qualifying levels for cardiometabolic risk factors. ...
  • Analysis of the Relationship of Leptin, High-Sensitivity C-Reactive...
    Abdul Ridha Abdullah, Haydar A. Hasan, Veena L. Raigangar
    Metabolic Syndrome and Related Disorders
    insulin, adiponectin, high-sensitivity [hs]-CRP, uric acid, blood sugar, high-density lipoprotein (HDL), low-density lipoprotein (LDL), total cholesterol, and triglycerides (TG). ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll